NameBio
Depends
Confidence: Medium
Buy if you actively flip or invest in domains and need comparable sales data.
Comparison
NameBio and Bishopi both land on Depends.
Buy if you actively flip or invest in domains and need comparable sales data.
Buy if you regularly appraise, research, or monitor domains and want it under $50/mo with a free test tier.
| Compare | NameBio | Bishopi |
|---|---|---|
| Verdict | Depends | Depends |
| Best for | Active domain flippers | Domain investors and flippers |
| Who it's not for | Non-domain businesses just naming a company | Enterprise threat-intel teams needing DomainTools-grade data |
| Privacy | No known public vulnerabilities found in the sources reviewed. | No known public vulnerabilities found in the sources reviewed. |
| Support quality | Customer service complaints published publicly | No usable evidence |
| Public sentiment | Domain investors treat NameBio as the default comps database but repeatedly warn its sales data is incomplete and auction-skewed.⁵ | Review pages exist on Trustpilot, Capterra, and G2, but available snippets give little detailed feedback; G2 comparison notes feature gaps versus competitors.13 |
| Biggest gotcha | Comps are incomplete . unreported private sales never appear. Never treat data as full market.⁵ | Credit-based limits: free tier is 100 credits; heavy volume gets pricey fast12 |